Annual report pursuant to Section 13 and 15(d)

Stock-Based Payments (Tables)

v3.10.0.1
Stock-Based Payments (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of status of stock options and changes during the period

A summary of the status of stock options as of December 31, 2018 and December 31, 2017 and changes during the year ended December 31, 2018 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

Intrinsic

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

 

Shares

 

 

Exercise Price

 

 

Life (in years)

 

 

(in thousands)

 

 

Outstanding at December 31, 2017

 

 

2,846,668

 

 

$

9.25

 

 

8.2

 

 

$

5,713

 

 

Granted

 

 

1,548,252

 

 

 

10.37

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(214,532

)

 

 

2.92

 

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(447,745

)

 

 

10.96

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

3,732,643

 

 

$

9.88

 

 

 

7.9

 

 

$

1,694

 

 

Exercisable at December 31, 2018

 

 

1,366,881

 

 

$

8.34

 

 

 

6.9

 

 

$

1,569

 

 

Schedule of weighted-average assumptions used in Black-Scholes option-pricing model

The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing model based on the following weighted-average assumptions:

 

 

 

 

Year Ended December 31,

 

 

 

 

 

2018

 

 

 

2017

 

 

 

2016

 

 

Weighted-average risk-free interest rate

 

 

 

2.56

 

%

 

 

2.07

 

%

 

 

1.36

 

%

Expected dividend yield

 

 

 

 

%

 

 

 

%

 

 

 

%

Expected option term (in years)

 

 

 

6.04

 

 

 

 

6.05

 

 

 

 

5.98

 

 

Volatility

 

 

 

90.26

 

%

 

 

87.83

 

%

 

 

85.39

 

%

Summary of stock-based compensation expense for stock options granted to employee and non-employees

The following table summarizes the stock-based compensation expense for stock options and restricted common stock granted to employees and non-employees recorded in the Company’s statements of operations:

 

 

 

Year Ended December 31,

 

 

 

 

2018

 

 

2017

 

 

2016

 

 

Research and development

 

$

2,412

 

 

$

1,666

 

 

$

2,980

 

 

General and administrative

 

 

4,198

 

 

 

2,753

 

 

 

1,254

 

 

Total stock-based compensation expense

 

$

6,610

 

 

$

4,419

 

 

$

4,234